Trends in Drug Safety February 28-March 2, 2007
Trends in Drug Safety February 28-March 2, 2007
San Francisco, CA
STRATEGIES FOR IMPROVING DRUG SAFETY
? Manage risk proactively to lower candidate attrition
? Decrease failure with pharmacodynamic biomarkers
? Feed information from clinical trials into discovery phase
? Quantitate benefit-risk management
? Review case study in drug-redirecting
? Gain insights from imaging biomarkers
? Select compounds in man
? Choose the right animal model
? Predict human sensitivity
? Develop biomarker assays
Sessions include:
? Cancer Biomarker Development
? Selecting First Dose in Humans
? How Many New Biomarkers do we Need? A Cost-Benefit Analysis of New
Biomarkers
? Correlating Imaging With Clinical Experience
? Exploratory Ind?s and Microdosing
Tel: 781-972-5464
Votes:4
Comments: 0